Prestige Consumer Healthcare Inc. buy BMO Capital Markets
Start price
15.11.23
/
50%
€53.50
Target price
15.11.24
€107.78
Performance (%)
42.99%
End price
16.11.24
€76.50
Summary
This prediction ended on 16.11.24 with a price of €76.50. The BUY prediction by BMO_Capital_Markets for Prestige Consumer Healthcare Inc. saw massive gains of 42.99%. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. | 6.667% | 6.667% | -31.077% |
| iShares Core DAX® | 1,01 % | 2,70 % | 4,36 % |
| iShares Nasdaq 100 | -6,47 % | -8,77 % | 18,00 % |
| iShares Nikkei 225® | -6,52 % | -12,58 % | 40,91 % |
| iShares S&P 500 | -2,72 % | -1,75 % | 16,97 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Prestige Consumer Healthcare Inc. diskutieren
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its price target lowered by analysts at BMO Capital Markets from $124.00 to $117.00. They now have an "outperform" rating on the stock.
Ratings data for PBH provided by MarketBeat
In the thread Trading Prestige Consumer Healthcare Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten